ITGB1 and ovarian cancer: Moreover, si-ITGB1 co-transfection with HULC inhibited the tumor-promoting effect of HULC by inhibiting tumor metastasis and invasion, suggesting that HULC may promote ovarian cancer progression by regulating ITGB1.